John Nicols

Director, President & Chief Executive Officer at Codexis, Inc.

John Nicols

John Nicols

Director, President & Chief Executive Officer at Codexis, Inc.

Biography

As President & CEO of Codexis since June 2012, John has been at the helm of the company through its turnaround and subsequent growth, positioning Codexis as a leader bringing protein-based innovations into a growing list of partnerships and industries. Prior to Codexis, John worked in various business leadership roles for more than 22 years at Albemarle Corporation, a maker of highly engineered specialty chemicals. There, John lead the growth of the company’s largest, billion dollar plus global catalyst business, turned around a struggling half billion dollar fine chemicals business, and expanded and globalized Albemarle’s flame retardants business. A native of New York City, John and his family have lived widely across the USA, and also enjoyed an exciting three year assignment in Tokyo, Japan in the late 1990’s. John received a bachelor’s degree in chemical engineering from the Polytechnic Institute of New York University (now NYU) and an MBA from the Massachusetts Institute of Technology.

Overview
Career Highlights

Codexis, Inc.

RelSci Relationships

872

Number of Boards

5

Birthday

1964

Age

57

Contact Data
Trying to get in touch with John Nicols? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals John Nicols likely has professional access to. A relationship does not necessarily indicate a personal connection.

President, Chief Executive Officer & Director at Nkarta, Inc.

Relationship likelihood: Strong

Chief Executive Officer & Chairman of the Board at Theravance Biopharma, Inc.

Relationship likelihood: Strong

Director, President & Chief Executive Officer at Amyris, Inc.

Relationship likelihood: Strong

Former President, Manufacturing Division at Merck & Co., Inc.

Relationship likelihood: Strong

Former Senator from North Dakota

Relationship likelihood: Strong

Co-Founder at Acepodia

Relationship likelihood: Strong

President & Chief Executive Officer at IntraBio

Relationship likelihood: Strong

President, Chief Executive Officer & Chairman at CytomX Therapeutics, Inc.

Relationship likelihood: Strong

Former Vice Chairman of the Board & Director at ARCA biopharma, Inc.

Relationship likelihood: Strong

Co-Chief Executive Officer at Alexandria Real Estate Equities, Inc.

Relationship likelihood: Strong

Paths to John Nicols
Potential Connections via
Relationship Science
You
John Nicols
Director, President & Chief Executive Officer at Codexis, Inc.
Education
M.B.A. Unknown
Class of 1985

Polytechnic Institute of New York University (formerly Polytechnic University), an affiliated institute of New York University, is a comprehensive school of engineering, applied sciences, technology and research, and is rooted in a 158-year tradition of invention, innovation and entrepreneurship: i2e. The institution, founded in 1854, is the nation’s second-oldest private engineering school. In addition to its main campus in New York City at MetroTech Center in downtown Brooklyn, it also offers programs at sites throughout the region, around the globe and remotely through NYUe-Poly. NYU-Poly is an integral part of NYU Abu Dhabi, NYU Shanghai and the NYU Center for Urban Science and Progress (CUSP) in downtown Brooklyn

MBA

MIT Sloan School of Management is the business school of the Massachusetts Institute of Technology, in Cambridge, Massachusetts, USA. MIT Sloan offers bachelor's, master's, and doctoral programs, as well as non-degree executive education. Its largest program is its full-time MBA, which is one of the most selective in the world, with students from more than 60 countries every year, and ranked #1 in more subjects than any other MBA program.

Career History
Senior Vice President, Strategic Development & Catalysts
1990 - 2012

At Albemarle, our 4,000+ employees around the globe put their ideas and innovations to work every day for communities and customers around the globe. We focus on creating solutions that meet society's needs in over 100 countries. We are a leading developer, manufacturer and marketer of complex chemicals and services that make life better for people everywhere. Whether it's Polymer Solutions, Catalysts or Fine Chemistry, we leverage our knowledge, experience and creativity to solve our customers' toughest challenges and deliver valuable solutions the right way. Our innovations are seen in everyday applications such as those that add life-saving properties to resins used in electronics and appliances, protect crops, reduce mercury emissions, safeguard food against bacteria, provide the active ingredients in pharmaceuticals and that help create cleaner transportation fuels. Our products and services create value for our customers by improving product performance, providing essential product attributes, lowering costs and simplifying processes. Through our innovation-driven culture and growth-focused strategies, Albemarle is committed to delivering exceptional performance that creates a better tomorrow for all of our stakeholders

Director, President & Chief Executive Officer
2012 - Current

Codexis, Inc. engages in the discovery, development, and sale of proteins. The company offers enzyme optimization services and developing biocatalyst products. The firm operates through the following segments: Performance Enzymes and Novel Biotherapeutics. Its technologies accelerate the development of manufacturing processes for active pharmaceutical ingredients fine chemicals, agrochemicals, food ingredients, detergents and biofuels. The company was founded in January 2002 and is headquartered in Redwood City, CA.

Professional
1990 - Prior

Ethyl Corp. provides blending and supply solutions. The firm supplies gasoline performance additives and diesel cetane improvers. It also offers terminal, storage, and trans loading services. The company was founded on February 15, 1887 and is headquartered in Richmond, VA.

Boards & Committees
Chairman
2015 - Current
Director
2014 - Current

California Biomedical Innovation Alliance is an American private company located in South San Francisco, CA, with operations in the United States. The firm provides biomedical advocacy and community services. Sara Radcliffe is currently the CEO of the company.The company says this about itself: California Life Sciences Association (CLSA) is the state’s largest and most influential life sciences advocacy and business leadership organization. With offices in Sacramento, San Diego, South San Francisco, Los Angeles and Washington DC, CLSA works closely with industry, government, academia and others to shape public policy, improve access to innovative technologies and grow California’s life sciences economy. CLSA serves bio technology, pharmaceutical, medical device and diagnostics companies, research universities and institutes, investors and service providers throughout the Golden State. CLSA was founded in 2015 when the Bay Area Bioscience Association (BayBio) and the California Healthcare Institute (CHI) merged.

Member, Board of Directors
2012 - ?

Codexis, Inc. engages in the discovery, development, and sale of proteins. The company offers enzyme optimization services and developing biocatalyst products. The firm operates through the following segments: Performance Enzymes and Novel Biotherapeutics. Its technologies accelerate the development of manufacturing processes for active pharmaceutical ingredients fine chemicals, agrochemicals, food ingredients, detergents and biofuels. The company was founded in January 2002 and is headquartered in Redwood City, CA.

Director
2014 - Current

California Life Sciences Association is an American nonprofit company located in South San Francisco, CA, that acts as a trade association which represents the life sciences industry of California. Mike Guerra is the current CEO, occupying that position since 2019.The company says this about itself: California Life Sciences Association (CLSA) is the state’s largest and most influential life sciences advocacy and business leadership organization. With offices in Sacramento, San Diego, South San Francisco, Los Angeles and Washington DC, CLSA works closely with industry, government, academia and others to shape public policy, improve access to innovative technologies and grow California’s life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device and diagnostics companies, research universities and institutes, investors and service providers throughout the Golden State.

Director
Prior

Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers.

Board Member
Prior

BayBio brings together the collective strength and experience of the world’s most innovative and productive life science cluster, helping companies grow, connect and advocate to solve some of humanity’s most pressing challenges. BayBio provides comprehensive support and solutions tailored to the unique needs of nearly 1000 Bay Area life science companies and institutions, delivering tangible value through group purchasing savings, capital access, government affairs & advocacy, networking and best-practice sharing. BayBio also supports the future of bioscience innovation through the BayBio Institute’s work in science education, career development and entrepreneurship.

Public Holdings
Restricted data only for RelSci Professional users.
Events
Speaker
New York City, NY
2013 UBS Global Healthcare Conference

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by John Nicols. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of John Nicols's profile does not indicate a business or promotional relationship of any kind between RelSci and John Nicols.